Development of Ocular Rosacea following Combined Ipilimumab and Nivolumab Treatment for Metastatic Malignant Skin Melanoma

Author(s):
Brouwer, N.J. (0000-0002-0854-0859); Haanen, J.B.A.G.; Jager, M.J.
Published
2017
Publication type
Article / Letter to editor
Ocular rosaceaIpilimumabNivolumabMetastatic melanomaToxicity
Date issued
2017-12-31
Language
English
Is part of
Ocular Oncology and Pathology (2017), Vol. 3, no. 3, p. 188-192
hdl
1887/115731
doi
10.1159/000455150